ANOVA PANCAN result package
Francesco Iorio, EMBL - European Bioinformatics Institute
result parsing started on 2016-03-31 19:01:47 iorio@ebi.ac.uk
Drug Domain: GDSC1000_paper_set, Analysis Domain: panCancer
Individual Feature analysis: loss_cnaPANCAN326_(SOX9)
Feature details and cell panel numbers
Binary feature equal to 1 for samples having the genomic region(s) cnaPANCAN326_(SOX9) deleted (see genomic region decoding file for further infos on this region)
Number of cell lines positive for this feature: 12
Statistically significant associations identified = 5
association id |
FEATURE |
Drug id |
Propr |
Public |
Drug Name |
Drug Target |
N FEATURE pos |
N FEATURE neg |
log max Conc tested |
FEATURE neg logIC50 MEAN |
FEATURE pos logIC50 MEAN |
FEATURE deltaMEAN IC50 |
FEATURE IC50 effectSize |
FEATURE neg Glass delta |
FEATURE pos Glass delta |
ANOVA FEATURE pval |
Tissue ANOVA pval |
MSI ANOVA pval |
ANOVA FEATURE FDR % |
a134 |
loss_cnaPANCAN326_(SOX9) |
306 |
1 |
1 |
TG101348 |
JAK2 |
10 |
911 |
2.33 |
2.29 |
4.18 |
1.89 |
1.2 * |
1.2 * |
1.2 * |
2.89e-05 |
1.14e-66 |
5.13e-01 |
3.5 |
a262 |
loss_cnaPANCAN326_(SOX9) |
179 |
1 |
1 |
5-Fluorouracil |
DNA antimetabolite |
10 |
903 |
3.47 |
3.54 |
5.39 |
1.85 |
1 * |
1 * |
1.8 * |
1.74e-04 |
1.95e-45 |
2.32e-01 |
11 |
a372 |
loss_cnaPANCAN326_(SOX9) |
252 |
1 |
1 |
WZ3105 |
CLK2, CNSK1E, FLT3, ULK1 |
10 |
911 |
0.247, 2.326 |
0.105 |
1.86 |
1.75 |
1 * |
1 * |
1 * |
3.83e-04 |
1.06e-57 |
9.63e-01 |
17 |
a503 |
loss_cnaPANCAN326_(SOX9) |
292 |
1 |
1 |
Masitinib |
KIT |
10 |
910 |
3 |
3.58 |
5.04 |
1.46 |
1.1 * |
1.1 * |
1.2 * |
7.34e-04 |
7.08e-50 |
2.29e-01 |
24 |
a512 |
loss_cnaPANCAN326_(SOX9) |
310 |
1 |
1 |
YM201636 |
FYV1 |
10 |
909 |
1.63 |
2.26 |
3.67 |
1.41 |
1.1 * |
1.1 * |
1.3 * |
7.59e-04 |
2.48e-36 |
1.67e-02 |
24 |
All-tests volcano plot